IndraLab
Statements
reach
"Conversely, selective disruption of the downstream interaction site, either by introducing the N to K mutation in the TRIP8b (1a-4) TPR domain or by ablating the TPR domain in the TRIP8b (1a-4) DeltaTPR construct, had essentially no effect on the ability of TRIP8b to inhibit HCN1 gating (XREF_FIG)."
reach
"In a previous study, our laboratory found that the action of TRIP8b to antagonize the cAMP dependent shift in HCN1 voltage gating observed in intact cells was greatly diminished upon patch excision when TRIP8b and HCN1 were expressed independently, perhaps because of instability of the complex and/or loss of some intracellular modulatory factor."
reach
"TRIP8b (1b-2) and TRIP8b (1b-2-4) cause a near complete loss of surface expression; TRIP8b (1a) causes a smaller but still marked ~ 10-fold decrease in HCN1 current density; TRIP8b (1a-2) has no effect on surface expression; and TRIP8b (1a-4) and TRIP8b (1a-2-4) cause up to a ~ 6-fold increase in surface expression."